Viewing Study NCT06547450



Ignite Creation Date: 2024-10-26 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 3:37 PM
Study NCT ID: NCT06547450
Status: RECRUITING
Last Update Posted: None
First Post: 2024-08-07

Brief Title: Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain
Sponsor: None
Organization: None

Study Overview

Official Title: Study of the Cost-efficacy and Acceptability of the Unified Protocol for Treatment of Emotional Disorders in Brief Groups in Primary Care Services in Spain PU-AP
Status: RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this project is to contribute to the improvement of psychological care received in primary care PC through the study of the cost-effectiveness and acceptability of the Unified Protocol for the treatment of emotional disorders in brief groups in primary care services in Spain PU-AP for the treatment of emotional disorders EDs the most prevalent in our society To do so a pilot study will be carried out and subsequently a randomized clinical trial to study the efficacy cost-effectiveness and acceptability of the Unified Protocol for the transdiagnostic treatment of EDs applied in 5 or 8 group sessions Finally the researchers will analyze whether there are specific patient profiles that will benefit more from one or the other condition The results will contribute to the personalization of the psychological treatment of users with EDs attending PC in the Spanish public health system
Detailed Description: Emotional disorders EDsincluding anxiety disorders unipolar mood disorders and related disorders are the most prevalent mental disorders in the general population In Spain anxiety disorders and mood disorders affect approximately two million 41 and two and half million 52 individuals respectively As a result of their prevalence in the society EDs have become an alarming health problem due to their associate costs These disorders have a direct cost of 22000 million euros 500 euros per capita and year The total expense of these disorders entails 22 of the Gross Domestic Product in Spain

In recent years several alternatives have been proposed to address this situation one of them being an increase in the number of clinical psychologists in our national health system NHS and especially their incorporation into primary care PC services

It is considered that the incorporation of psychology in PC will help to reduce referral to specialized care because it will be possible to carry out a more exhaustive screening and determine which cases do not require psychological treatment which cases should be referred to other health care resources and which cases can be treated in PC usually mild-moderate TE Another alternative to mitigate the excessive demand for care regardless of the level of care is the use of group psychological interventions a cost-effective format for systems with limited resources such as our NHS

Transdiagnostic interventions like the Unified Protocol for the Treatment of EDs UP in brief group format has emerged as a viable option for treating EDs in PC services

The aim of the present study is to analyze the efficacy cost-effectiveness and acceptability of the Unified Protocol for the transdiagnostic treatment of EDs applied in 5 or 8 group sessions

Furthermore it will try to find out which characteristics of the participants eg gender clinical diagnoses transdiagnostic dimensions affected symptom severity predict a better outcome eg clinical improvement and quality of life as a function of the sessions received Thus in the future it will be possible to offer the optimal number of sessions according to specific profiles personalization of treatments

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None